Zhiyi Dong Selected Research

Glucose (Dextrose)

1/2021

The Cardiovascular and Cerebrovascular Health in North China From 2006 to 2011: Results From the KaiLuan Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhiyi Dong Research Topics

Disease

3	Adenocarcinoma of Lung 01/2023 - 12/2020
3	Neoplasms (Cancer) 10/2022 - 01/2022
3	Lung Neoplasms (Lung Cancer) 09/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2022
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Malignant Mesothelioma 09/2022
1	Hypoxia (Hypoxemia) 03/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Body Weight (Weight, Body) 01/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2020
1	Adenocarcinoma 12/2020

Drug/Important Bio-Agent (IBA)

1	CL 387785IBA 01/2023
1	Circular RNAIBA 10/2022
1	Glutamine (L-Glutamine)FDA Link 10/2022
1	B7-H1 AntigenIBA 09/2022
1	CarcinogensIBA 09/2022
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 09/2022
1	Sincalide FDA Link 03/2022
1	LuciferasesIBA 03/2022
1	Cisplatin (Platino)FDA LinkGeneric 03/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	SmokeIBA 01/2022
1	Gefitinib (Iressa)FDA Link 01/2022
1	CholesterolIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2020
1	Tyrosine Kinase InhibitorsIBA 12/2020
1	Growth Factor ReceptorsIBA 12/2020

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2020
1	Radiotherapy 01/2022